Clarigo finalCalculatorBRCA Tumor MASTR PlusBRCA HC MASTR Plus


New Product Launch of Tumor Hotspot MASTR Plus

Niel – Belgium, July 6th, 2015 – We are pleased to announce the release of the Tumor Hotspot MASTR™ Plus molecular assay, research use only, for the identification of frequently occurring hotspot mutations in various types of solid tumors.

Press Release: Multiplicom launches a new test for the diagnosis of chronic lymphocytic leukemia

Niel – Belgium, June 30th, 2015 – Multiplicom N.V. announces the release of a new gene panel, the CLL MASTR™ Plus kit, to improve the diagnosis of patients with chronic lymphocytic leukemia. This is the most common form of leukemia in adults and has a highly variable outcome. Multiplicom’s test helps to steer the treatment options to stabilize the disease.


5-9 Sep 27th European Congress of Pathology

Serbia I Belgrade

24 Sep Clarigo Webinar

WebEx I Online

12-16 Oct BioJapan 2015

Japan I Yokohama